James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 11,000 shares at $1.54 ($17K) on 2019-06-05, disclosed to the SEC on 2019-06-06.
Open-market purchase of $17k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.53 | 200 | $306 | 1.8% |
| 2 | $1.53 | 400 | $612 | 3.6% |
| 3 | $1.54 | 1,863 | $3K | 16.8% |
| 4 | $1.55 | 1,000 | $2K | 9.1% |
| 5 | $1.56 | 7,537 | $12K | 68.8% |
| Total | $1.55 avg | 11,000 |
| $17K |
| 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |